An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A. Soucy, Steven Langston, Courtney Cullis et al.|Nature|2009Cited by 2k
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituJames E. Brownell, Lawrence R. Dick, Michael D. Sintchak et al.|Molecular Cell|2010Cited by 461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L. Hyer, Neil Bence, Michael A. Milhollen et al.|Nature Medicine|2018Cited by 453
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Stephen Grossman et al.|Journal of Medicinal Chemistry|2021Cited by 205
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Ruth Adams et al.|Journal of Medicinal Chemistry|2011Cited by 33